X

Mankind Pharma Ltd Q1FY25; 25% rise in Profits

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.

Financial Results:

Mankind Pharma Ltd reported Revenues for Q1FY25 of ₹2,403.00 Crores up from ₹2,092.00 Crore year on year, a rise of 14.87%.

Total Expenses for Q1FY25 of ₹1,920.00 Crores up from ₹1,665.00 Crores year on year, a rise of 15.32%.

Consolidated Net Profit of ₹513.00 Crores up 25.43% from ₹409.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹12.82, up 25.44% from ₹10.22 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post